3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
CNS
1
Conditions
Glioma
20
Glioblastoma
15
Brain Neoplasms
11
Neuroblastoma
4
Neoplasms
4
Astrocytoma
4
Sarcoma
3
Prostatic Neoplasms
2
Neurofibromatosis 1
2
Neoplastic Cells, Circulating
2
Meningioma
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Radiation Injuries
1
Polycystic Kidney, Autosomal Recessive
1
Pituitary Neoplasms
1
Pheochromocytoma
1
Parkinsonian Disorders
1
Paraganglioma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurofibromatosis-Noonan syndrome
1
Neurofibromatoses
1
Neoplasms, Germ Cell and Embryonal
1
Interventions
mirdametinib
3
Imatinib Mesylate
3
Surveys and Questionnaires
2
tipifarnib
1
talimogene laherparepvec
1
pirfenidone
1
nilotinib
1
emvododstat
1
diphenylcyclopropenone
1
cabozantinib
1
binimetinib
1
Sunitinib
1
Sirolimus
1
Sevoflurane
1
Propofol
1
Percutaneous Collagen Induction
1
Nitrous Oxide
1
Magnetic Resonance Spectroscopy
1
Lidocaine
1
Lasers, Solid-State
1
Lasers
1
Glycopyrrolate
1
Dexmedetomidine
1
Blood Specimen Collection
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurofibromatoses
×
Blood Specimen Collection
×
CNS
×
Clear all
NCT06147414
2026-04-23
DANNIgene
Assistance Publique - Hôpitaux de Paris
Recruiting
550 enrolled